Targeting EGFR activity in blood vessels is sufficient to inhibit tumor growth and is accompanied by an increase in VEGFR-2 dependence in tumor endothelial cells.

Dhara N. Amin,D. Bielenberg,E. Lifshits,J. Heymach,M. Klagsbrun
DOI: https://doi.org/10.1016/j.mvr.2008.01.002
IF: 3.75
2008-05-01
Microvascular Research
Abstract:
What problem does this paper attempt to address?